A randomized controlled study to compare the effect of rosuvastatin 2.5mg with pravastatin 10mg on plasma lipids in Japanese patients with hypercholesterolemia

Trial Profile

A randomized controlled study to compare the effect of rosuvastatin 2.5mg with pravastatin 10mg on plasma lipids in Japanese patients with hypercholesterolemia

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Jul 2009

At a glance

  • Drugs Rosuvastatin (Primary) ; Pravastatin
  • Indications Hypercholesterolaemia
  • Focus Therapeutic Use
  • Acronyms ASTRO-1
  • Most Recent Events

    • 27 Jul 2009 New trial record.
    • 14 Jun 2009 Primary endpoint 'Low density lipoprotein cholesterol level' has been met according to results presented at the 15th International Symposium on Atherosclerosis.
    • 14 Jun 2009 Results presented at the 15th International Symposium on Atherosclerosis.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top